Use of a fluorinated probe to quantitatively monitor amino acid binding preferences of ruthenium(ii) arene complexes.

In order to address outstanding questions about ruthenium complexes in complex biological solutions, 19F NMR spectroscopy was used to follow the binding preferences between fluorinated RuII(η6-arene)(bipyridine) complexes and protected amino acids and glutathione. Reporting what ruthenium compounds bind to in complex environments has so far been restricted to relatively qualitative methods, such as mass spectrometry and X-ray spectroscopic methods; however, quantitative information on the species present in the solution phase cannot be inferred from these techniques. Furthermore, using 1H NMR, in water, to distinguish and monitor a number of different complex RuII(η6-arene) adducts forming is challenging. Incorporating an NMR active heteroatom into ruthenium organometallic complexes provides a quantitative, diagnostic 'fingerprint' to track solution-phase behaviour and allow for unambiguous assignment of any given adduct. The resulting 19F NMR spectra show for the first time the varied, dynamic behaviour of organoruthenium compounds when exposed to simple biomolecules in complex mixtures. The rates of formation of the different observed species are dramatically influenced by the electronic properties at the metal, even in a closely related series of complexes in which only the electron-donating properties of the arene ligand are altered. Preference for cysteine binding is absolute: the first quantitative solution-phase evidence of such behaviour

The molecular systems composed of the charmed mesons in the HSˉ+h.c.H\bar{S}+h.c. doublet

We study the possible heavy molecular states composed of a pair of charm mesons in the H and S doublets. Since the P-wave charm-strange mesons $D_{s0}(2317)$ and $D_{s1}(2460)$ are extremely narrow, the future experimental observation of the possible heavy molecular states composed of $D_s/D_s^\ast$ and $D_{s0}(2317)/D_{s1}(2460)$ may be feasible if they really exist. Especially the possible $J^{PC}=1^{--}$ states may be searched for via the initial state radiation technique.Comment: 42 pages, 4 tables, 31 figures. Improved numerical results and Corrected typos

Oncological outcomes of visibly complete transurethral resection prior to neoadjuvant chemotherapy for bladder cancer

ABSTRACT Purpose: To evaluate the potential oncologic benefit of a visibly complete transurethral resection of a bladder tumor (TURBT) prior to neoadjuvant chemotherapy (NAC) and radical cystectomy (RC). Materials and Methods: We identified patients who received NAC and RC between 2011-2021. Records were reviewed to assess TURBT completeness. The primary outcome was pathologic downstaging (<ypT2N0), with complete pathologic response (ypT0N0) and survival as secondary endpoints. Logistic regression and Cox proportional hazards models were utilized. Results: We identified 153 patients, including 116 (76%) with a complete TURBT. Sixty-four (42%) achieved <ypT2N0 and 43 (28%) achieved ypT0N0. When comparing those with and without a complete TURBT, there was no significant difference in the proportion with <ypT2N0 (43% vs 38%, P=0.57) or ypT0N0 (28% vs 27%, P=0.87). After median follow-up of 3.6 years (IQR 1.5-5.1), 86 patients died, 37 died from bladder cancer, and 61 had recurrence. We did not observe a statistically significant association of complete TURBT with cancer-specific or recurrence-free survival (p≥0.20), although the hazard of death from any cause was significantly higher among those with incomplete TURBT even after adjusting for ECOG and pathologic T stage, HR 1.77 (95% CI 1.04-3.00, P=.034). Conclusions: A visibly complete TURBT was not associated with pathologic downstaging, cancer-specific or recurrence-free survival following NAC and RC. These data do not support the need for repeat TURBT to achieve a visibly complete resection if NAC and RC are planned

Static Spherically Symmetric Solutions in F(R) Gravity

A Lagrangian derivation of the Equation of Motion (EOM) for static spherically symmetric metrics in F(R) modified gravity is presented. For a large class of metrics, our approach permits to reduce the EOM to a single equation and we show how it is possible to construct exact solutions in $F(R)$-gravity. All known exact solutions are recovered. We also exibit a new non trivial solution with non constant Ricci scalar.Comment: 8 pages, published version, some references added, a minor modificatio

Black hole solutions in F(R) gravity with conformal anomaly

In this paper, we consider $F(R)=R+f(R)$ theory instead of Einstein gravity with conformal anomaly and look for its analytical solutions. Depending on the free parameters, one may obtain both uncharged and charged solutions for some classes of $F(R)$ models. Calculation of Kretschmann scalar shows that there is a singularity located at $r=0$, which the geometry of uncharged (charged) solution is corresponding to the Schwarzschild (Reissner-Nordstr\"om) singularity. Further, we discuss the viability of our models in details. We show that these models can be stable depending on their parameters and in different epoches of the universe.Comment: 12 pages, one figur

Phenomenology of Pc(4380)+, Pc(4450)+ and related states

The $P_c(4380)^+$ and $P_c(4450)^+$ states recently discovered at LHCb have masses close to several relevant thresholds, which suggests they can be described in terms of meson-baryon degrees of freedom. This article explores the phenomenology of these states, and their possible partners, from this point of view. Competing models can be distinguished by the masses of the neutral partners which have yet to be observed, and the existence or otherwise of further partners with different isospin, spin, and parity. Future experimental studies in different decay channels can also discriminate among models, using selection rules and algebraic relations among decays. Among the several possible meson-baryon pairs which could be important, one implies that the states are mixtures of isospins 1/2 and 3/2, with characteristic signatures in production and decay. A previous experimental study of a Cabibbo-suppressed decay showed no evidence for the states, and further analysis is required to establish the significance of this non-observation. Several intriguing similarities suggest that $P_c(4450)^+$ is related to the $X(3872)$ meson.Comment: 16 pages, 1 figure. Journal version (some very minor changes from arXiv v1

Impact of COVID-19 on cardiovascular testing in the United States versus the rest of the world

Objectives: This study sought to quantify and compare the decline in volumes of cardiovascular procedures between the United States and non-US institutions during the early phase of the coronavirus disease-2019 (COVID-19) pandemic. Background: The COVID-19 pandemic has disrupted the care of many non-COVID-19 illnesses. Reductions in diagnostic cardiovascular testing around the world have led to concerns over the implications of reduced testing for cardiovascular disease (CVD) morbidity and mortality. Methods: Data were submitted to the INCAPS-COVID (International Atomic Energy Agency Non-Invasive Cardiology Protocols Study of COVID-19), a multinational registry comprising 909 institutions in 108 countries (including 155 facilities in 40 U.S. states), assessing the impact of the COVID-19 pandemic on volumes of diagnostic cardiovascular procedures. Data were obtained for April 2020 and compared with volumes of baseline procedures from March 2019. We compared laboratory characteristics, practices, and procedure volumes between U.S. and non-U.S. facilities and between U.S. geographic regions and identified factors associated with volume reduction in the United States. Results: Reductions in the volumes of procedures in the United States were similar to those in non-U.S. facilities (68% vs. 63%, respectively; p = 0.237), although U.S. facilities reported greater reductions in invasive coronary angiography (69% vs. 53%, respectively; p < 0.001). Significantly more U.S. facilities reported increased use of telehealth and patient screening measures than non-U.S. facilities, such as temperature checks, symptom screenings, and COVID-19 testing. Reductions in volumes of procedures differed between U.S. regions, with larger declines observed in the Northeast (76%) and Midwest (74%) than in the South (62%) and West (44%). Prevalence of COVID-19, staff redeployments, outpatient centers, and urban centers were associated with greater reductions in volume in U.S. facilities in a multivariable analysis. Conclusions: We observed marked reductions in U.S. cardiovascular testing in the early phase of the pandemic and significant variability between U.S. regions. The association between reductions of volumes and COVID-19 prevalence in the United States highlighted the need for proactive efforts to maintain access to cardiovascular testing in areas most affected by outbreaks of COVID-19 infection